EGRX

Eagle Pharmaceuticals Inc
33.21
-0.54 (-1.60%)

Eagle Pharmaceuticals Inc. (EGRX) Fundamentals

Eagle Pharmaceuticals Inc is a specialty pharmaceutical company. The company develops and commercializes injectable products in the areas of critical care, orphan diseases, and oncology. Its product portfolio consists of four approved products: Argatroban, Ryanodex, Belrapzo, and Bendeka. The company currently has multiple product candidates in advanced stages of development and is under review for approval by the Food and Drug Administration.
SHARE INFORMATION
Market Cap$ 439,285,140
Shares Outstanding13,015,856
Float6,959,032
Percent Float53.47%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 171,546,000
Latest Fiscal EPS$ -0.66
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions434
Institutional Holdings Date2022-12-31
Institutional Bought Previous 3 Months1,214,553
Institutional Holdings Percent176.5%
Institutional Sold Previous 3 Months2,119,933
Insider Holdings Date2022-12-31
Insider Bought Previous 3 Months-
Insider Holdings Percent14.3
Insider Sold Previous 3 Months461
Insider Shares Owned1,860,525
TRADING INFO
52 Week High$ 53.78
52 Week Low$ 24.35
52 Week High Change$ -24.31
21 Day Moving Average$ 31.59
21 Day Extended Moving Average$ 32.2712
50 Day Moving Average$ 32.5316
50 Day Extended Moving Average$ 32.1326
200 Day Moving Average$ 37.1395
200 Day Extended Moving Average$ 36.3126
10 Day Average Volume137,027
20 Day Average Volume144,921
30 Day Average Volume159,163
50 Day Average Volume146,226
Alpha-0.010724
Beta0.8778
Standard Deviation0.107807
R20.192790
7 Day Price Change$ -0.16
7 Day Percent Change-0.47%
21 Day Price Change$ 3.29
21 Day Percent Change10.8%
30 Day Price Change$ 5.24
30 Day Percent Change18.38%
Month to Date Price Change$ 4.52
Month to Date Percent Change15.46%
Quarter to Date Price Change$ 4.52
Quarter to Date Percent Change15.46%
180 Day Price Change$ -7.98
180 Day Percent Change-19.12%
200 Day Price Change$ -11.12
200 Day Percent Change-24.78%
Year to Date Price Change$ 4.52
Year to Date Percent Change15.46%

Eagle Pharmaceuticals Inc. (EGRX) Key Ratios

PROFITABILITY
EBIT Margin17.4%
EBITDA Margin19.9%
Pre-Tax Profit Margin14.6%
Profit Margin Count10.74%
Gross Margin70.7%
Profit Margin TOT10.74%
INCOME STATEMENTS
Revenue$ 255,911,000
Revenue Per Share$ 19.6615
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book5.40
Total Debt To Equity0.30
Int Coverage20.70
Current Ratio1.50
Leverage Ratio1.60
Quick Ratio0.90
Long Term Debt To Capital0.10
VALUATION MEASURES
PE Ratio20.30
Enterprise Value$ 488,675,140
Price to Sales1.7166
Price to Free Cash-7.20
PE High Last 5 Years67.00
Price To Book1.90
Price To Cash Flow20.70
PE Low Last 5 Years9.10
Price to Tangible Book5.40
MANAGEMENT EFFECTIVENESS
Receivables Turnover3.70
Invoice Turnover2.10
Assets Turnover0.80
Return Assets7.05
Return on Equity10.95
Return on Capital8.87

Eagle Pharmaceuticals Inc. (EGRX) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorErnst & Young LLP
CEOScott L. Tarriff
Emplyoees114
Last AuditUQ
CIK0000827871
IndustryDrug Manufacturers
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address50 Tice Boulevard
Suite 315
Woodcliff Lake, NJ 7677
Websitehttp://www.eagleus.com
Facsimile-
Telephone+1 201 326-5300
Emailinfo@eagleus.com


Your Recent History
NASDAQ
EGRX
Eagle Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.